Osteoporosis is a major confounder in observational studies investigating bisphosphonate therapy in aortic stenosis

J Am Coll Cardiol. 2012 Sep 11;60(11):1027; author reply 1027. doi: 10.1016/j.jacc.2012.04.048.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aortic Valve Stenosis / drug therapy*
  • Aortic Valve*
  • Bone Density Conservation Agents / therapeutic use*
  • Calcinosis / drug therapy*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans

Substances

  • Bone Density Conservation Agents
  • Diphosphonates